People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Pharma, Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alessa Therapeutics, Inc. | — | Pharma | Series B | $31.6M | $129.6M | 2025 |
| Ludus Technologies, Inc. | — | Software / Tech | Series A | $12.0M | $46.1M | 2025 |
| Ribonaut Therapeutics, Inc. | — | Biotechnology | Series A | $6.9M | $79.7M | 2022 |
Zachary Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Zachary Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lim | 1 | 14 |
| Douglas Crawford | 1 | 8 |
| Cam Gallagher | 1 | 7 |
| Peter Parker | 1 | 6 |
| LUSONG LUO | 1 | 3 |
| Doug Crawford | 1 | 3 |
| Jake Colognesi | 1 | 3 |
| John Maroney | 1 | 3 |
| Steven Tregay | 1 | 2 |
| Steve Tregay | 1 | 2 |
| Annie Mitsak | 1 | 2 |
| Kevin Schneider | 1 | 2 |
| Matthew Disney | 1 | 2 |
| Pamela Munster | 1 | 1 |
| Jessica Childs-Disney | 1 | 1 |
| Sasa Kukic | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.